Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D05RUJ
|
|||
| Former ID |
DIB007255
|
|||
| Drug Name |
G-1128
|
|||
| Synonyms |
MATAGEN oligonucleotides; Antisense [cancer], Genta/Chugai; Anti-bcr-abl, Genta/Chugai
Click to Show/Hide
|
|||
| Drug Type |
Antisense drug
|
|||
| Indication | Chronic myelogenous leukaemia [ICD-11: 2A20.0; ICD-10: C92.1; ICD-9: 205.1] | Discontinued in Phase 2 | [1] | |
| Company |
Genta Inc
|
|||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800004653) | |||
| REF 2 | Pharmaceutical Design And Development: A Molecular Biology Approach, T V Ramabhadran, 2005. Page(219). | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.